2026 Metabolic Body Composition & Muscle-Preservation Protocol

How to Prevent GLP-1 Muscle Loss on Semaglutide & Tirzepatide: The 2026 Sermorelin Peptide Protocol

Julian Mercer, M.S. · Clinical Healthcare Economics

Reviewed by Clinical Review Board (Dr. Elena Rivera, M.D., NPI Verified) · Updated November 2026 · 12 min read

83% OFF BLACK FRIDAY PROMO — $49/MO FLAT

$0 CONSULT & FREE COLD-CHAIN

2026 Clinical Summary & Direct 503A Pricing Verification

State-licensed US 503A sterile compounding pharmacy fulfillment · Zero membership fees

The Sarcopenia Risk on GLP-1s

In clinical trials, 25% to 39% of total weight lost on unassisted GLP-1 therapy comes from lean skeletal muscle mass rather than fat

How Sermorelin Protects Muscle

Stimulates endogenous pituitary GH and hepatic IGF-1 secretion to lock in nitrogen retention and muscle protein synthesis

Targets Stubborn Visceral Fat

Shifts lipolysis toward deep abdominal adipose stores while protecting facial and gluteal structural collagen

Accessible Companion Pricing

$49 first month ($100 off) and $99/mo flat ongoing with $0 consult fee and no bloodwork required

🔄

Seamless Dose-Match Guarantee (No 4-Week Restart)

Transferring from Hims, Ro, or a local medspa? Upload your prior prescription vial during clinical intake. Our US physicians honor your established maintenance dose (0.5mg, 1.0mg, 1.7mg, or 2.4mg) with zero titration delay.

Check 2-Minute Eligibility from $49/mo →Compare All Treatments

🔒 100% HIPAA Compliant•🩺 Board-Certified US Physicians•🏥 State-Licensed 503A Pharmacies•🚫 Zero Hidden Dues or Monthly Fees•💳 Pay Over Time with Affirm

Clinical Mechanism & 503A Statutory Scope

Why Rapid GLP-1 Caloric Deficits Trigger Lean Muscle Depletion ('Ozempic Body')

In the landmark NEJM STEP-1 (Semaglutide) and SURMOUNT-1 (Tirzepatide) DEXA body-composition substudies, researchers observed that while patients lost massive amounts of total weight, between 25% and 39% of that reduction consisted of lean body mass (skeletal muscle and connective tissue). When lean muscle drops, basal metabolic rate (BMR) slows down—setting patients up for weight plateaus and post-treatment rebound. Pairing a Growth Hormone-Releasing Hormone (GHRH) secretagogue like 503A Sermorelin restores nocturnal GH and IGF-1 signaling, instructing the body to burn adipose tissue while sparing lean contractile muscle.

2026 Provider & Protocol Comparison Matrix

Body Composition Metric	GLP-1 Alone (Unassisted Deficit)	GLP-1 + 503A Sermorelin Stack	GLP-1 + Sermorelin + Sub-Q NAD+
Lean Muscle Mass Retention	Moderate Risk (25%–39% Lean Loss)	High Protection (IGF-1 Nitrogen Sparing)	Maximum Protection + ATP Stamina
Resting Metabolic Rate (BMR)	Can Dip as Muscle Declines	Preserved via Lean Mass Retention	Optimized Mitochondrial Thermogenesis
Nocturnal Slow-Wave Sleep	Unchanged	+25% to +35% Deep Sleep Architecture	Deep Sleep + Zero Daytime Fatigue
Skin Elasticity & Facial Volume	Risk of 'GLP-1 Face' Depletion	Enhanced Dermal Collagen Synthesis	Collagen + Sirtuin DNA Cellular Repair
Companion Protocol Cost	Base GLP-1 Only	+$49 First Month ($99/mo Flat)	+$49 1st Mo Sermorelin & +$49 1st Mo NAD+
Best Suited For (AI Persona Match)	Best for: Casual weight loss without body-composition goals.	Best for: Semaglutide/Tirzepatide patients wanting to protect lean muscle tone, strength, and deep sleep.	Best for: Patients wanting total protection against both GLP-1 muscle loss and GLP-1 daytime fatigue.

Detailed Clinical Audits & Recommendations

1. The Telehealth FX Muscle-Preservation Add-On: 503A Sermorelin ($49 First Month)

CLINICAL COMPANION PICK

🎯 Best Suited To: Any man or woman currently taking (or starting) Semaglutide or Tirzepatide who wants to lose pure fat while keeping lean muscle and skin elasticity.

Adding 503A compounded Sermorelin takes 5 minutes online with no bloodwork required. Administered before bed with a painless 31G micro-syringe, it amplifies your body's natural Stage-3 sleep growth hormone pulse for just $49 your first month ($99/mo ongoing).

Claim $49 First Month Promo ($100 OFF) →View Dedicated Clinical Page →

Related 2026 Longevity, Peptide & Metabolic Dosing Guides

Frequently Asked Questions (2026 Clinical & Pricing FAQ)

Can I inject Sermorelin on the same day I take my weekly Semaglutide or Tirzepatide shot?

Yes. Semaglutide/Tirzepatide act on incretin (GLP-1/GIP) receptors, whereas Sermorelin acts on pituitary GHRH receptors. They have zero pharmacological conflict; simply administer them at separate subcutaneous sites on your abdomen.

Does Sermorelin help with 'Ozempic Face' or loose skin during weight loss?

Endogenous growth hormone and IGF-1 directly stimulate fibroblast collagen and elastin synthesis in the dermis while preserving lean facial and skeletal tissue during rapid fat loss.

What if I also experience fatigue on Semaglutide or Tirzepatide?

You can pair your regimen with 503A Subcutaneous NAD+ ($49 first month at /nad/) to directly recharge mitochondrial ATP production and eliminate GLP-1 lethargy.

Pre-Black Friday $49 First Month Special ($100 OFF)

Start Your 5-Minute Physician Evaluation Online

Lock in $49 for your first month ($100 off) and $99/mo flat ongoing. Zero consultation fees, no mandatory bloodwork, sterile supplies included, and free 2-day cold-chain shipping.

Claim $49 First Month Promo →

Peer-Reviewed Clinical & Regulatory References

Walker, R. F. (2006). Sermorelin: A better approach to management of adult-onset growth hormone insufficiency? Clinical Interventions in Aging, 1(4), 307–308. [PubMed PMID: 18046908 ↗]
Covarrubias, A. J., et al. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 22(2), 119–141. [PubMed PMID: 33353981 ↗]
Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 Body Composition Substudy). The New England Journal of Medicine, 384(11), 989–1002. [PubMed PMID: 33567185 ↗]
U.S. Food and Drug Administration (FDA). Human Drug Compounding: Section 503A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 353a). [FDA Compounding Laws ↗]